Clinical trials for cell and gene therapies: Progressing the pipeline
Tracks
Track 3
| Friday, November 1, 2024 |
| 2:10 PM - 2:55 PM |
Details
This session will discuss the growth of cell and gene therapy clinical trials in Australia during the last 4-5 years and look forward to the projected growth within the global context. Considerations will include infrastructure requirements, workforce needs, market access and regulatory pathways, equitable access, inpatient and outpatient trials and decentralisation, as well as recruitment, and participant and clinical experiences and outcomes (PROMs/PREMs).
Speaker
Dr. Shu Lam
Director, Business Development APAC
ProPharma
Panellist
Dr Michelle Lorentzos
Paediatric Neurologist and Clinical Trials Lead
Sydney Children’s Network
Panellist
Ms Paula Stoddart
Clinical Business Manager
Miltenyi Biotec
Panellist
